Submission Details
| 510(k) Number | K132555 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 14, 2013 |
| Decision Date | December 20, 2013 |
| Days to Decision | 128 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Statement |
K132555 is an FDA 510(k) clearance for the HEVYLITE HUMAN IGG KAPPA KIT AND HEVYLITE HUMAN IGG LAMBDA KIT, a Immunoglobulin G Kappa Heavy And Light Chain Combined (Class II — Special Controls, product code PCN), submitted by The Binding Site (Birmingham, GB). The FDA issued a Cleared decision on December 20, 2013, 128 days after receiving the submission on August 14, 2013. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5510.
| 510(k) Number | K132555 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 14, 2013 |
| Decision Date | December 20, 2013 |
| Days to Decision | 128 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Statement |
| Product Code | PCN — Immunoglobulin G Kappa Heavy And Light Chain Combined |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5510 |
| Definition | Intended For The In-vitro Quantification Of Igg Kappa Concentration In Human Serum. |